Final results of a phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma

BACKGROUND: Many patients with classical Hodgkin lymphoma show increased programmed death-1 ligand expression in Reed–Sternberg cells. We report the final results of a phase II study of nivolumab, an anti-programmed death-1 monoclonal antibody, in Japanese patients with relapsed or refractory classi...

Descripción completa

Detalles Bibliográficos
Autores principales: Maruyama, Dai, Terui, Yasuhito, Yamamoto, Kazuhito, Fukuhara, Noriko, Choi, Ilseung, Kuroda, Junya, Ando, Kiyoshi, Hattori, Akira, Tobinai, Kensei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579338/
https://www.ncbi.nlm.nih.gov/pubmed/32776097
http://dx.doi.org/10.1093/jjco/hyaa117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579338/
https://www.ncbi.nlm.nih.gov/pubmed/32776097
http://dx.doi.org/10.1093/jjco/hyaa117

Ejemplares similares